Susquehanna International Group
GRTX

Susquehanna International Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Susquehanna International Group’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,400
Closed -$79.2K – 13259
2023
Q2 		$79.2K Buy
25,400
+14,200
+127% +$42.2K ﹤0.01% 11109
2023
Q1 		$28.7K Buy
+11,200
New +$23.1K ﹤0.01% 11930
2022
Q2 		– Sell
-214,300
Closed -$510K – 14225
2022
Q1 		$510K Buy
214,300
+88,700
+71% +$231K ﹤0.01% 8915
2021
Q4 		$577K Buy
+125,600
New +$415K ﹤0.01% 8796

Other funds holding GRTX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Susquehanna International Group's GRTX Position: Q2 2024 in Review

Susquehanna International Group sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 286,180 shares — an estimated $40.1K sold.

Susquehanna International Group first reported a position in GRTX in Q4 2021 and held it in 9 quarters. The position peaked at $671K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Susquehanna International Group reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 286,180 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $40.1K.
  • Susquehanna International Group first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Susquehanna International Group's Galera Therapeutics, Inc. Common Stock position peaked at $671K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.